Ghidini, M.; Petrillo, A.; Botticelli, A.; Trapani, D.; Parisi, A.; La Salvia, A.; Sajjadi, E.; Piciotti, R.; Fusco, N.; Khakoo, S.
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. J. Clin. Med. 2021, 10, 1412.
https://doi.org/10.3390/jcm10071412
AMA Style
Ghidini M, Petrillo A, Botticelli A, Trapani D, Parisi A, La Salvia A, Sajjadi E, Piciotti R, Fusco N, Khakoo S.
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. Journal of Clinical Medicine. 2021; 10(7):1412.
https://doi.org/10.3390/jcm10071412
Chicago/Turabian Style
Ghidini, Michele, Angelica Petrillo, Andrea Botticelli, Dario Trapani, Alessandro Parisi, Anna La Salvia, Elham Sajjadi, Roberto Piciotti, Nicola Fusco, and Shelize Khakoo.
2021. "How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches" Journal of Clinical Medicine 10, no. 7: 1412.
https://doi.org/10.3390/jcm10071412
APA Style
Ghidini, M., Petrillo, A., Botticelli, A., Trapani, D., Parisi, A., La Salvia, A., Sajjadi, E., Piciotti, R., Fusco, N., & Khakoo, S.
(2021). How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches. Journal of Clinical Medicine, 10(7), 1412.
https://doi.org/10.3390/jcm10071412